I was watching the ABCTV science show Catalyst, and there was a story about the weird sleep habits of teenagers, and among the talking heads shown in the story was the Australian psychiatrist Professor Ian Hickie, who has had a long and happy professional relationship with a number of pharmaceutical companies, and I said he was sure to be there to mention some melatonin-based drug as a treatment. Was I wrong?
Staying Up Late.
21 July 2011
Catalyst.
ABCTV
http://www.abc.net.au/catalyst/stories/3275022.htm
Prof. Hickie shares advice and some rather confused ideas about evolution and health in some extended interviews:
http://www.abc.net.au/catalyst/sleep/
Not long after watching this episode of Catalyst I came across an article in The Conversation from May of this year that provided some interesting and rather concerning information about the professor's relationship with one melatonin-like drug, Agomelatine produced by Servier, a company which has supported Prof. Hickie's research. Take special note of the full content of the comments about this article:
Tackling depression and poor sleep with one drug.
by Sunanda Creagh
18 May 2011
The Conversation.
http://theconversation.edu.au/tackling-depression-and-poor-sleep-with-one-drug-1332
No comments:
Post a Comment